[Pharmacology of salicylates in children. I. General comments, absorption, and excretion]
Related Experiment Videos
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Anti-inflammatory treatment in dysfunction of pulmonary surfactant in meconium-induced acute lung injury.
Advances in experimental medicine and biology·2012
[Biochemical aspects of fetal hypoxia].
Ceska gynekologie·2011
[Biophysical methods in diagnosis of intrapartal fetal hypoxia].
Ceska gynekologie·2011
Comparison of the effects of low-dose vs. high-dose aminophylline on lung function in experimental meconium aspiration syndrome.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2009
Combination of budesonide and aminophylline diminished acute lung injury in animal model of meconium aspiration syndrome.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2009
[Dangers in external treatment of skin diseases in childhood].
Ceskoslovenska pediatrie·1994
[The effect of growth hormone therapy on thyroid parameters].
Ceskoslovenska pediatrie·1994
Causative factors and outcomes of pyogenic granulomas presenting to a hospital eye clinic.
Clinical & experimental optometry·2026
Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy.
Alimentary pharmacology & therapeutics·2026
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: a qualitative study.
Expert opinion on drug delivery·2026
Ensuring patient rights, safety, and welfare in "compassionate use" of drugs.
Perspectives in clinical research·2026
Pediatric obesity pharmacotherapy: a practical guide for general pediatricians.
Current opinion in pediatrics·2026
Old Drugs, New Targets: Molecular Docking Insights into Repurposing Proton Pump Inhibitors for the TLR4/MD-2, NLRP3, and C5aR1 Axes in Autoimmune Liver Diseases.
Pharmaceuticals (Basel, Switzerland)·2026